定量成像对急性心肌梗死的诊断价值
研究纳入2020年5月至2021年4月天津市第一中心医院经冠状动脉造影确诊的急性心肌梗死(AMI)患者24例,在确诊后(9±4)天行心脏磁共振(CMR,Philips Ingenia 3.0-T),并在慢性心肌梗死(CMI)期3个月和6个月各复查一次CMR;同期按年龄、性别匹配纳入26例健康志愿者及非特异性胸痛且CMR无异常的门诊患者作为对照组。结果显示AMI组增强前T1值、T2值和细胞外容积(ECV)均显著高于对照组(均P<0.05);ECV在AMI期升高后趋于稳定,6个月时与3个月时无显著差异(均P>0.05);增强前T1、T2值在AMI期显著升高,3个月后降低,6个月后显著下降(均P<0.05)。ROC曲线显示增强前T1和T2值区分AMI与CMI的特异度均为100%,敏感度分别为72.7%和100%。作者认为增强前心肌T1、T2值是无创诊断AMI并区分AMI与CMI的方法,对临床治疗和随访有重要意义。
要点
- AMI组增强前T1值(ms)1438.7±173.4 vs 对照组1269.2±42.3,增强前T2值(ms)49.8±9.3 vs 21.7±4.0,ECV(%)33.2±10.2 vs 27.2±2.1,均P<0.05。
- ECV在AMI期(%)33.2±10.2 vs 3个月32.4±5.1 vs 6个月27.7±4.9,各时间点比较均P>0.05。
- 增强前T1值(ms)AMI期1438.7±173.4 vs 6个月1272.1±25.2,增强前T2值(ms)49.8±9.3 vs 29.0±4.0,均P<0.05。
- ROC曲线:增强前T1、T2值区分AMI与CMI的特异度均为100%,敏感度分别为72.7%、100%。
- 作者认为增强前心肌T1、T2值是诊断AMI并区分AMI与CMI的无创方法。
适用人群与场景
- 2020年5月至2021年4月天津市第一中心医院经冠状动脉造影确诊的急性心肌梗死(AMI)患者24例,在确诊后(9±4)天行CMR。
- 对照组为同期按年龄、性别匹配的健康志愿者及非特异性胸痛且CMR检查无异常的门诊患者共26例。
诊断标准与关键阈值
- AMI诊断依据冠状动脉造影。
- CMR扫描序列包括平扫Cine、T2加权(STIR)、native T1/T2 mapping,增强扫描包括灌注、晚期钆增强、post-T1 mapping。
研究设计与关键结果
- 研究类型为病例对照研究,AMI组24例,对照组26例;AMI组在确诊后(9±4)天行CMR,慢性心肌梗死(CMI)期于3个月和6个月各复查一次CMR。
- AMI组增强前T1值(ms)1438.7±173.4 vs 对照组1269.2±42.3,增强前T2值(ms)49.8±9.3 vs 21.7±4.0,ECV(%)33.2±10.2 vs 27.2±2.1,均P<0.05。
- ECV(%)在AMI期33.2±10.2 vs 3个月32.4±5.1 vs 6个月27.7±4.9,各时间点比较均P>0.05。
- 增强前T1值(ms)AMI期1438.7±173.4 vs 6个月1272.1±25.2,增强前T2值(ms)49.8±9.3 vs 29.0±4.0,均P<0.05。
- ROC曲线显示增强前T1、T2值区分AMI与CMI的特异度均为100%,敏感度分别为72.7%、100%。
证据类型、等级与局限
- 证据类型:病例对照研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,T1 mapping、T2 mapping联合ECV可清晰诊断缺血性心肌病,尤其是增强前心肌T1、T2值是无创诊断AMI的方法,并能区分AMI与CMI,对患者临床治疗和随访有重要意义。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVE: To explore the diagnostic performance of cardiac magnetic resonance imaging (CMR) with T1 mapping and T2 mapping for detection of acute phase of ischemic cardiomyopathy.
METHODS: Twenty-four patients with acute myocardial infarction (AMI) detected by coronary angiography from May 2020 to April 2021 in Tianjin First Center Hospital were selected. All patients underwent CMR (Philips Ingenia 3.0-T) at (9±4) days after definite diagnosis, which was defined as the first diagnosis. After 3 months and 6 months of chronic myocardial infarction (CMI) phase, one CMR was performed. On the same period with age and sex matching, a total of 26 cases of healthy volunteers and outpatient with non-specific chest pain and CMR examination without abnormality as control group. Plain scan included Cine, T2-weighted (STIR), and native T1/T2 mapping. The enhanced scan included perfusion, late gadolinium enhancement, post-T1 mapping. The changes of myocardial quantitative parameters before and after myocardial infarction were compared. Receiver operator characteristic curves (ROC curve) were developed to evaluate, compare, and distinguish the changes in the AMI group and the CMI group after 6 months.
RESULTS: Pre-enhanced T1 value, T2 value and extracellular volume (ECV) of AMI group were significantly higher than those of control group [pre-enhanced T1 value (ms): 1 438.7±173.4 vs. 1 269.2±42.3, pre-enhanced T2 value (ms): 49.8±9.3 vs. 21.7±4.0 , ECV (%): 33.2±10.2 vs. 27.2±2.1, all P < 0.05]. ECV was significantly higher in AMI (%: 33.2±10.2 vs. 27.2±2.1), but stabilized after 3 months (%: 33.2±10.2 vs. 32.4±5.1), and after 6 months later (%: 27.7±4.9 vs. 32.4±5.1), there were no significant difference (all P > 0.05). Pre-enhanced T1 and T2 values were significantly higher in AMI, lower after 3 months, but significantly decreased after 6 months [pre-enhanced T1 values (ms): 1 438.7±173.4 vs. 1 272.1±25.2, pre-enhanced T2 values (ms): 49.8±9.3 vs. 29.0±4.0, all P < 0.05]. The ROC curve showed that the specificity of pre-enhanced T1 and T2 values between AMI and CMI were 100%, and the sensitivity were 72.7%, 100%, respectively, pre-enhanced T1 and T2 value could be better distinguish between AMI and CMI diagnosis method.
CONCLUSIONS: T1 mapping and T2 mapping with ECV can clearly diagnosis ischemic cardiomyopathy, especially pre-enhanced myocardial T1 and T2 values which is non-invasive diagnosis method of AMI, and can distinguish AMI or CMI, has a great significance to the patient's clinical treatment and follow-up.
参考来源
- Cui Q, Yu J, Ge X, et al. [The diagnostic value of quantitative imaging for acute myocardial infarction]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2022. PMID: 35387725. doi:10.3760/cma.j.cn121430-20210825-01272
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。